Back to Search
Start Over
Harnessing cyclotides to design and develop novel peptide GPCR ligands.
- Source :
-
RSC chemical biology [RSC Chem Biol] 2020 Jul 22; Vol. 1 (4), pp. 177-191. Date of Electronic Publication: 2020 Jul 22 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- Cyclotides are plant-derived cyclic, disulfide-rich peptides with a unique cyclic cystine knot topology that confers them with remarkable structural stability and resistance to proteolytic degradation. Recently, cyclotides have emerged as promising scaffold molecules for designing peptide-based therapeutics. Here, we provide examples of how engineering cyclotides using molecular grafting may lead to the development of novel peptide ligands of G protein-coupled receptors (GPCRs), today's most exploited drug targets. Integrating bioactive epitopes into stable cyclotide scaffolds can lead to improved pharmacokinetics and oral activity as well as selectivity and high enzymatic stability. We also discuss and highlight the importance of engineered cyclotides as novel tools to study GPCR signaling.<br />Competing Interests: There are no conflicts to declare.<br /> (This journal is © The Royal Society of Chemistry.)
Details
- Language :
- English
- ISSN :
- 2633-0679
- Volume :
- 1
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- RSC chemical biology
- Publication Type :
- Academic Journal
- Accession number :
- 34458757
- Full Text :
- https://doi.org/10.1039/d0cb00062k